Literature DB >> 15180228

Total hip replacement in younger patients: survival rate after avascular necrosis of the femoral head.

Wolfgang Schneider1, Karl Knahr.   

Abstract

BACKGROUND: A high risk of loosening has been reported in replacements performed because of avascular necrosis. PATIENTS AND METHODS: To study cementless total hip replacement (THR) in younger patients with avascular necrosis (AVN), we analyzed retrospectively the outcome in 129 cases: 46 Mittelmeier monobloc ceramic hips (22 cases with AVN), and 83 Zweymüller total hip systems (35 cases with AVN) clinically and radiographically.
RESULTS: At follow-up, 17 Mittelmeier prostheses (10 AVN) and 4 Zweymüller prostheses (none with AVN) had been revised. The diagnosis did not affect the implant survival, but the Zweymüller THR fared better than the Mittelmeier system. The main reason for revision of Mittelmeier implants was aseptic loosening, 3 of 4 Zweymüller revisions were necessary due to polyethylene wear. This difference was confirmed by the radiographic evaluation of the still intact implants: Zweymüller THR showed better values for signs of osseointegration, radiolucent lines around the implants and migration, but more acetabular wear. None of these differences was affected by the AVN diagnosis.
INTERPRETATION: We could not confirm that AVN is a risk factor in total hip replacement.

Entities:  

Mesh:

Year:  2004        PMID: 15180228     DOI: 10.1080/00016470412331294385

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  13 in total

1.  Osteogenic abilities of bone marrow stromal cells are not defective in patients with osteonecrosis.

Authors:  Jeong Joon Yoo; Won Seok Song; Kyung-Hoi Koo; Kang Sup Yoon; Hee Joong Kim
Journal:  Int Orthop       Date:  2008-02-19       Impact factor: 3.075

2.  Total hip arthroplasty in the treatment of osteonecrosis of the femoral head: then and now.

Authors:  Carlos J Lavernia; Jesus M Villa
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

3.  Development of periprosthetic bone mass density around the cementless Metha® short hip stem during three year follow up-a prospective radiological and clinical study.

Authors:  Laura Augustin; Sarah Boller; Cathrein Bobach; Alexander Jahnke; Gafar Adam Ahmed; Markus Rickert; Bernd Alexander Ishaque
Journal:  Int Orthop       Date:  2018-09-03       Impact factor: 3.075

4.  Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.

Authors:  Siddharth A Mahure; Joseph A Bosco; James D Slover; Jonathan Vigdorchik; Richard Iorio; Ran Schwarzkopf
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

Review 5.  Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review.

Authors:  Henning R Johannson; Michael G Zywiel; David R Marker; Lynne C Jones; Mike S McGrath; Michael A Mont
Journal:  Int Orthop       Date:  2010-02-25       Impact factor: 3.075

6.  [Long-term results of thrust plate prostheses: comparison of patients younger than and older than 50 years].

Authors:  S Wienbeck; N Osada; E Basad; H Stürz; B A Ishaque
Journal:  Orthopade       Date:  2011-03       Impact factor: 1.087

7.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

8.  Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample.

Authors:  Aaron J Johnson; Michael A Mont; Audrey K Tsao; Lynne C Jones
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

9.  Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.

Authors:  Gildasio Cerqueira Daltro; Vitor Fortuna; Eliane Silva de Souza; Marcela Miranda Salles; Ana Claudia Carreira; Roberto Meyer; Songeli Menezes Freire; Radovan Borojevic
Journal:  Stem Cell Res Ther       Date:  2015-05-29       Impact factor: 6.832

10.  Incidence of hip replacement among national health insurance enrollees in Taiwan.

Authors:  Yu-Shu Lai; Hung-Wen Wei; Cheng-Kung Cheng
Journal:  J Orthop Surg Res       Date:  2008-09-15       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.